Nature Communications (Feb 2021)

Structure of papain-like protease from SARS-CoV-2 and its complexes with non-covalent inhibitors

  • Jerzy Osipiuk,
  • Saara-Anne Azizi,
  • Steve Dvorkin,
  • Michael Endres,
  • Robert Jedrzejczak,
  • Krysten A. Jones,
  • Soowon Kang,
  • Rahul S. Kathayat,
  • Youngchang Kim,
  • Vladislav G. Lisnyak,
  • Samantha L. Maki,
  • Vlad Nicolaescu,
  • Cooper A. Taylor,
  • Christine Tesar,
  • Yu-An Zhang,
  • Zhiyao Zhou,
  • Glenn Randall,
  • Karolina Michalska,
  • Scott A. Snyder,
  • Bryan C. Dickinson,
  • Andrzej Joachimiak

DOI
https://doi.org/10.1038/s41467-021-21060-3
Journal volume & issue
Vol. 12, no. 1
pp. 1 – 9

Abstract

Read online

The SARS-CoV-2 papain-like protease (PLpro) is of interest as an antiviral drug target. Here, the authors synthesize and characterise naphthalene-based inhibitors for PLpro and present the crystal structures of PLpro in its apo state and with the bound inhibitors, which is of interest for further structure-based drug design efforts.